BE901218A - Chlorocefadroxil monohydrate. - Google Patents

Chlorocefadroxil monohydrate.

Info

Publication number
BE901218A
BE901218A BE0/214120A BE214120A BE901218A BE 901218 A BE901218 A BE 901218A BE 0/214120 A BE0/214120 A BE 0/214120A BE 214120 A BE214120 A BE 214120A BE 901218 A BE901218 A BE 901218A
Authority
BE
Belgium
Prior art keywords
monohydrate
gram
alpha
dimethylformamide
acetonitrile
Prior art date
Application number
BE0/214120A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE901218A publication Critical patent/BE901218A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/214120A 1983-12-06 1984-12-05 Chlorocefadroxil monohydrate. BE901218A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8319463A FR2555989B1 (fr) 1983-12-06 1983-12-06 Monohydrate de chlorocephadroxyle

Publications (1)

Publication Number Publication Date
BE901218A true BE901218A (fr) 1985-06-05

Family

ID=9294877

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214120A BE901218A (fr) 1983-12-06 1984-12-05 Chlorocefadroxil monohydrate.

Country Status (25)

Country Link
JP (1) JPH0794461B2 ( )
KR (1) KR920001769B1 ( )
AT (1) AT386411B ( )
AU (1) AU567780B2 ( )
BE (1) BE901218A ( )
CA (1) CA1246545A ( )
CH (1) CH662569A5 ( )
CY (1) CY1559A ( )
DE (1) DE3444367A1 ( )
DK (1) DK579984A ( )
ES (1) ES8605279A1 ( )
FI (1) FI81104C ( )
FR (1) FR2555989B1 ( )
GB (1) GB2150931B ( )
GR (1) GR81159B ( )
HK (1) HK72590A ( )
IE (1) IE57832B1 ( )
IT (1) IT1177370B ( )
LU (1) LU85670A1 ( )
MY (1) MY102192A ( )
NL (1) NL8403670A ( )
SE (1) SE8406171L ( )
SG (1) SG48890G ( )
YU (1) YU45221B ( )
ZA (1) ZA849415B ( )

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505697A1 (fr) * 1981-05-12 1982-11-19 Humblot Bernard Unite perfectionnee de soudage electrique

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US516047A (en) * 1894-03-06 Wire bed-bottom
US3489752A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US3781282A (en) * 1971-01-20 1973-12-25 W Garbrecht Cephalosporin process and product
YU39709B (en) * 1972-09-15 1985-04-30 Bristol Myers Co Process for producing cephalosporin
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
JPS5356311A (en) * 1976-10-28 1978-05-22 Toyama Chem Co Ltd Cefalexin monohydrate having novel crystal form and process for preparationof the same
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate

Also Published As

Publication number Publication date
GB8430753D0 (en) 1985-01-16
AU3632184A (en) 1985-06-13
IE843117L (en) 1985-06-06
JPH0794461B2 (ja) 1995-10-11
SG48890G (en) 1990-08-17
KR920001769B1 (ko) 1992-03-02
DE3444367C2 ( ) 1993-04-29
CY1559A (en) 1991-03-22
ES538235A0 (es) 1986-03-16
NL8403670A (nl) 1985-07-01
FI844756L (fi) 1985-06-07
FR2555989A1 (fr) 1985-06-07
DK579984A (da) 1985-06-07
GR81159B (en) 1985-04-08
CH662569A5 (fr) 1987-10-15
FI844756A0 (fi) 1984-12-03
FR2555989B1 (fr) 1987-02-20
ES8605279A1 (es) 1986-03-16
SE8406171D0 (sv) 1984-12-05
IE57832B1 (en) 1993-04-21
DE3444367A1 (de) 1985-06-20
ATA386384A (de) 1988-01-15
YU45221B (en) 1992-05-28
YU207384A (en) 1987-12-31
FI81104B (fi) 1990-05-31
LU85670A1 (fr) 1985-09-12
IT8423909A0 (it) 1984-12-05
GB2150931A (en) 1985-07-10
AT386411B (de) 1988-08-25
JPS60139695A (ja) 1985-07-24
HK72590A (en) 1990-09-21
IT1177370B (it) 1987-08-26
SE8406171L (sv) 1985-06-07
MY102192A (en) 1992-04-30
DK579984D0 (da) 1984-12-05
CA1246545A (en) 1988-12-13
FI81104C (fi) 1990-09-10
IT8423909A1 (it) 1986-06-05
KR850004494A (ko) 1985-07-15
GB2150931B (en) 1987-07-29
ZA849415B (en) 1985-07-31
AU567780B2 (en) 1987-12-03

Similar Documents

Publication Publication Date Title
PT81946A (fr) Procede de preparation de nouveaux derives de l'acide alpha-<oxo-2-hexahydro-2,4,5,6,7,7a-thieno(3,2-c)pyridyl-5>phenyl acetique et de compositions pharmaceutiques les contenant
NO843836L (no) Terapeutisk aktive sulfamatderivater
FR2479229B1 (fr) Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
RO86439A (ro) Procedeu pentru prepararea unor derivati de acid ascorbic
RO92583A (ro) Procedeu pentru prepararea unor derivati de imidazo-piridina
DK390587A (da) 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre
PT77826B (fr) Procede de preparation de nouveaux derives de thieno<2,3-b> pyrrole et de compositions pharmaceutiques les contenant
JPS54132592A (en) 3,7-di-substituted-3-cephem-4-carboxylic acid derivative, its salt, and their preparation
FR2405258A1 (fr) Procede de preparation et de purification du facteur citrovorum par ouverture de noyau d'imidazoline et nouveau produit ainsi obtenu
TNSN86004A1 (fr) Compose pharmaceutiquement actif et procede pour sa preparation
KR870001216A (ko) 3-프로페닐 세팔로스포린 용매화물
EP0228593A3 (en) Composition for cleaning water-containing devices
MA21902A1 (fr) Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant .
BE901218A (fr) Chlorocefadroxil monohydrate.
ES2093666T3 (es) Derivados de los acidos 7-(2,7-diazabiciclo(3,3.0)octil)-3-quinolon- y -naftiridon carboxilicos.
GB1323502A (en) Erythromycin derivatives
FR2694558B1 (fr) Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
US4210662A (en) Side chain sulphoxide metabolites
FR2416013A1 (fr) Derives d'acide (-)-(cis)-1,2-epoxypropylphosphonique, leur preparation et compositions pharmaceutiques les contenant
TNSN98061A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
PT78776A (fr) Procede de preparation de derives de l'acide bicyclo(3.2.1.)carboxylique et de compositions pharmaceutiques les contenant
FR2362856A1 (fr) 7-(2-(benzoyl substitue) amino) acetamido) cephalosporines actives contre les microorganismes de l'espece pseudomonas
FR2515516B1 (fr) Composition pharmaceutique pour le traitement de la lithiase renale infectee contenant de l'acide propionohydroxamique ou ses sels acceptables en pharmacie
GB1415453A (en) Composition and process for producing aquarium water having improved properties
FR2549371B1 (fr) Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19951231